#Anthocyanins #OxidativeStress #Microbiota
#CardiovascularHealth #Bioavailability
Anthocyanins are
water-soluble plant pigments
from the flavonoid family, responsible for the red, purple, and blue hues in
many fruits and vegetables. Beyond their coloring function, they exhibit strong
bioactive potential—particularly
antioxidant, anti-inflammatory, and
microbiota-modulating effects. These properties have sparked growing interest
in the fields of nutritional prevention and chronic disease management.
However, despite these proven in vitro benefits,
their actual efficacy in humans remains limited due to low bioavailability,
rapid degradation in the body, and high interindividual variability in
response. This review aimed to clarify the mechanisms of action, metabolism,
and potential strategies to enhance the clinical effectiveness of anthocyanins.
Anthocyanins: Healing Through Color
This in-depth review examines the metabolic
journey of anthocyanins from ingestion to excretion. Less than 1% of the
ingested dose reaches the bloodstream in its native form. After ingestion,
anthocyanins undergo early degradation in the stomach and small intestine, and
are then converted into phenolic metabolites by the gut microbiota—particularly
by bacterial species such as Bacteroides, Clostridium, or Lactobacillus.
Although these metabolites differ from the original anthocyanins, they retain
significant biological activity.
Functionally, anthocyanins target multiple
molecular pathways. They regulate oxidative stress through the Nrf2 pathway,
reduce the expression of pro-inflammatory cytokines (IL-6, TNF-α), and enhance
endothelial function.
Animal and clinical studies suggest benefits for blood
pressure, insulin sensitivity, lipid profile, and even cognition. The
microbiota plays a dual role: it transforms anthocyanins and is itself
favorably modulated by them (increased Bifidobacteria, reduced
pathobionts).
Read next: Cardiovascular diseases: the leading cause of death among women in France
Pigments Full of Promise?
Anthocyanins, with their diverse biological
properties, offer a promising nutritional approach against chronic
diseases—particularly cardiovascular, metabolic, and neurodegenerative
disorders. This review sought to illuminate their mechanisms of action and
explore why in vivo effects remain modest despite strong in vitro
evidence.
Current data highlight the
essential role of
the gut microbiota in anthocyanin transformation and activation. However,
poor
bioavailability, metabolic variability among individuals, and
chemical
instability hinder their direct clinical impact.
To enhance their efficacy, several strategies
are under consideration: encapsulation, co-administration with prebiotics or
enzyme inhibitors, and selecting more stable plant matrices rich in
anthocyanins. Higher-quality clinical trials, including specific biomarkers of
absorption and activity, are needed to validate the therapeutic potential of
these pigments within a targeted nutritional framework.
Read next: Metabolism in danger: could your plate make the difference?
